- Home
- GROW vs MIRA Comparison
GROW vs MIRA Comparison
Compare GROW & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- MIRA
- Stock Information
- Founded
- GROW 1968
- MIRA 2020
- Country
- GROW United States
- MIRA United States
- Employees
- GROW N/A
- MIRA N/A
- Industry
- GROW Investment Managers
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- MIRA Health Care
- Exchange
- GROW Nasdaq
- MIRA Nasdaq
- Market Cap
- GROW 34.9M
- MIRA 17.1M
- IPO Year
- GROW N/A
- MIRA 2023
- Fundamental
- Price
- GROW $2.51
- MIRA $2.04
- Analyst Decision
- GROW
- MIRA Strong Buy
- Analyst Count
- GROW 0
- MIRA 2
- Target Price
- GROW N/A
- MIRA $14.00
- AVG Volume (30 Days)
- GROW 56.0K
- MIRA 2.1M
- Earning Date
- GROW 12-12-2024
- MIRA 11-11-2024
- Dividend Yield
- GROW 3.56%
- MIRA N/A
- EPS Growth
- GROW N/A
- MIRA N/A
- EPS
- GROW 0.09
- MIRA N/A
- Revenue
- GROW $10,984,000.00
- MIRA N/A
- Revenue This Year
- GROW N/A
- MIRA N/A
- Revenue Next Year
- GROW N/A
- MIRA N/A
- P/E Ratio
- GROW $27.33
- MIRA N/A
- Revenue Growth
- GROW N/A
- MIRA N/A
- 52 Week Low
- GROW $2.38
- MIRA $0.51
- 52 Week High
- GROW $3.11
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- GROW 53.23
- MIRA 79.14
- Support Level
- GROW $2.40
- MIRA $1.05
- Resistance Level
- GROW $2.54
- MIRA $1.99
- Average True Range (ATR)
- GROW 0.06
- MIRA 0.15
- MACD
- GROW 0.01
- MIRA 0.11
- Stochastic Oscillator
- GROW 75.06
- MIRA 95.38
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.